MOH Falls -31% In 5-Day Spree On Drastic 2026 Guidance Cut
Molina Healthcare (MOH) – a managed healthcare provider for Medicaid and Medicare beneficiaries – hit a 5-day losing streak, with cumulative losses over this period amounting to -31%. The company’s market cap has crashed by about $2.9 Bil over the last 5 days and currently stands at $6.6 Bil.
The stock has YTD (year-to-date) return of 27.7% compared to 1.4% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Slide?
[1] Q4 Earnings Miss & Weak 2026 Guidance
- The Iran War Trade Investors Are Missing
- Broken Windows: How Microsoft Loses Its AI Premium
- GE Aerospace: Blue-Chip Performance, Red-Line Valuation
- Why Betting Against Amazon Stock In 2022 Was A Mistake
- How To Earn 12% Yield While Waiting to Buy RCL 30% Cheaper
- Where Could The Next Breakout for Applied Materials Stock Come From
- Reported Q4 adjusted loss of $2.75 per share, missing consensus profit estimates [4, 5, 21]
- 2026 EPS guidance of at least $5.00, far below analyst consensus of ~$13.71 [18, 19]
- Impact: Stock plummeted ~33% in after-hours trading, Exceptional trading volume spike
[2] Analyst Price Target Downgrades
- TD Cowen lowered price target to $144 from $175 [3]
- Jefferies cut price target to $139 from $160, citing Medicaid concerns [14]
- Impact: Sustained selling pressure, Negative institutional sentiment
Opportunity or Trap?
Below is our take on valuation.
There is a near-equal mix of good and bad in MOH stock given its overall Moderate operating performance and financial condition. Taken together with its Very Low valuation, this makes the stock look Attractive (For details, see Buy or Sell MOH).
But here is the real interesting point.
You are reading about this -31% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has a risk model designed to reduce exposure to losers.
Returns vs S&P 500
The following table summarizes the return for MOH stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | MOH | S&P 500 |
|---|---|---|
| 1D | -1.6% | -0.3% |
| 5D (Current Streak) | -30.9% | 0.3% |
| 1M (21D) | -30.9% | -0.4% |
| 3M (63D) | -17.5% | 3.2% |
| YTD 2026 | -27.7% | 1.4% |
| 2025 | -40.4% | 16.4% |
| 2024 | -19.4% | 23.3% |
| 2023 | 9.4% | 24.2% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: MOH Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 132 S&P constituents with 3 days or more of consecutive gains and 16 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 99 | 7 |
| 4D | 12 | 4 |
| 5D | 8 | 1 |
| 6D | 9 | 3 |
| 7D or more | 4 | 1 |
| Total >=3 D | 132 | 16 |
Key Financials for Molina Healthcare (MOH)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $34.1 Bil | $40.6 Bil |
| Operating Income | $1.6 Bil | $1.7 Bil |
| Net Income | $1.1 Bil | $1.2 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $11.4 Bil | $11.5 Bil |
| Operating Income | $373.0 Mil | $137.0 Mil |
| Net Income | $255.0 Mil | $79.0 Mil |
The losing streak MOH stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.